Protective effect of caffeine against high sugar-induced transcription of microRNAs and consequent gene silencing: A study using lenses of galactosemic mice

Molecular Vision

Volumn 19, Issue , 2013, Pages 493-500

  Varma, Shambhu D ^a   Kovtun, Svitlana ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAFFEINE; COMPLEMENTARY DNA; MICRORNA; RNA DIRECTED DNA POLYMERASE;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA SYNTHESIS; DOWN REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; LENS; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; RNA PROBE; RNA TRANSCRIPTION; TRANSCRIPTION REGULATION;

ANIMALS; CAFFEINE; CATARACT; DISEASE MODELS, ANIMAL; GALACTOSE; GALACTOSEMIAS; GENE SILENCING; HUMANS; LENS, CRYSTALLINE; MICE; MICE, INBRED STRAINS; MICRORNAS; OXIDATIVE STRESS; TRANSCRIPTION, GENETIC;

EID: 84874400060     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Lee RC, Fein Baum RL, Ambros V. The C. elegans hetererochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843-54. [PMID: 8252621.
2. Bartel DP. Micro RNAs: Target recognition and regulatory functions. Cell 2009; 136:215-33. [PMID: 19167326.
3. Lim LP, Nelson CL, Garrett-Engel P, Grimson A, Schelter JM, Castle J, Bartel DP, Linsley PS, Johnson JM. Microarray analysis shows that some microRNAs down regulate large number of target mRNAs. Nature 2005; 433:769-73. [PMID: 15685193.
4. Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol 2007; 8:23-6. [PMID: 17183358.
5. Bentwich I, Avniel A, Karv Y, Aharnoov R, Giald S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E. Spector, Bentwich z. Identification of hundreds of conserved and non-conserved human microRNAs. Nat Genet 2005; 37:766-70. [PMID: 15965474.
6. Lewis BP, Burge CB, Bartles DP. Conserved seed pairing, often flanked by adenosine, indicates that thousands of human genes are micro RNA targets. Cell 2005; 120:15-20. [PMID: 15652477.
7. Tan Y, Zhang B, Wu T, Wu T, Skogerbø G, Zhu X, Guo X, He S. Chen, R. Transcriptional inhibition of Hoxd4 expression by noncoding RNAs in human breast cancer cells. BMC Mol Biol 2009; 10:12-21. [PMID: 19232136.
8. Hawkins PG. Morris kV. RNA and transcriptional modulation of gene expression. Cell Cycle 2008; 7:602-7. [PMID: 18256543.
9. Morozova N, Zinovyev A, Nonne N, Pritchard LL, Gorban AN, Harel-Bellan A. Kinetic signatures of microRNA modes of action. RNA 2012; 18:1635-55. [PMID: 22850425.
10. Fumiaki S, Soken T, Stephen J. M, Shumaizu K. Micro RNAs and epigenetics. A Mmini Review. FEBS J 2011; 278:1998-1609
11. Chuang JC, Jones PA. Epigenetics and MicroRNAs. Pediatr Res 2007; 61:24R-9R. [PMID: 17413852.
12. Mraz M, Pospisilova S, Malinova K. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 2009; 50:506-9. [PMID: 19347736.
13. Lu J, Getz G, Miska EA, Alvarez-Salvedra E, Lamb J. MicroRNA expression profiles classify human cancers. Nature 2005; 435:834-8. [PMID: 15944708.
14. Nielsen BS, Jorgensen S, Gog JU, Sokilde R, Christensen IJ, Hansen U. Brunner, Baser A, Moller S, Nielsen JJ, High levels of micro RNA-21 in the stroma of colorectal cancers predict short disease free survival in state II colon cancer patients. Clin Exp Metastasis 2011; 28:27-38. [PMID: 21069438].
15. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang DZ. Targeted deletion of dicer in the heart leads to dilated cardio-myopathy and heart failure. Proc Natl Acad Sci USA 2008; 105:2111-6. [PMID: 18256189.
16. van Rooij E, Sutherland LB, Liu N, Williams AH, McNally J, Gerard RD, Richardson RA, Olson EN. A signature pattern of stress responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci USA 2006; 103:18255-60. [PMID: 17108080.
17. Tatsuguchi M, Seok HY, Callis TE, Thomson J. M, Chen JF, Newman M, Rojas M, Hammond SM, Wang Da-Zhi. Expression of microRNA is dynamically regulated during cardiomyocyte hypertrophy. J Mol Cell Cardiol 2007; 42:1137-41. [PMID: 17498736.
18. Maes OC, Chertkow HM, Wang E, Schipper HM. MicroRNA. Implications for Alzheimer disease and other human CNS disorders. Curr Genomics 2009; 10:154-68. [PMID: 19881909].
19. Beveridge NJ, Gardiner E, Carroll AP, Tooney PA, Cairns MJ. Schizophrenia is associated with an increase in cortical microRNA biogenesis. Mol Psychiatry 2010; 15:1176-9. [PMID: 19721432.
20. Xiao J, Luo X, Lin H, Zhang Y, Lu Y, Wang N, Zhang Y, Yang B, Wang Z. MicroRNA miR-133 suppresses K+ Channel expression contributing to QT prolongation in diabetic hearts. J Biol Chem 2011; 286:12363-7.
21. Tang X, Tang G, Ozcan S. Role of microRNA in diabetes. Biochim Biophys Acta 2008; 9:697-701
22. Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. Br J Ophthalmol 1993; 77:2-6. [PMID: 8435392.
23. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, Dawber TR. The Framingham eye study. II. Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am J Epidemiol 1977; 106:33-41. [PMID: 141882.
24. Tabin G, Chen M, Espandar L. Cataract surgery for the developing world. Curr Opin Ophthalmol 2008; 19:55-9. [PMID: 18090899.
25. Klein BE, Klein R, Moss SE. Incidence of cataract surgery in the Wisconsin. Epidemiologic Study of Diabetic Retinopathy. Am J Ophthalmol 1995; 119:295-300. [PMID: 7872389.
26. Klein BE, Klein R, Wang Q, Moss SE. Older-onset of diabetes and lens opacities. The Beaver Dam Eye Study. Ophthalmic Epidemiol 1995; 2:49-55. [PMID: 7585233.
27. Klein BE, Klein R, Moss MS. Prevalence of cataracts in a population-based study of persons with diabetes mellitus. Ophthalmology 1985; 92:1191-6. [PMID: 4058882.
28. The diabetes control and complications trials research group. Diabetes 1995; 44:968-83. [PMID: 7622004.
29. Mitchel HS, Dodge WM. Cataracts in rats fed high galactose rations. J Nutr 1935; 9:37-49
30. Keller HW, Koch HR, Ohrloff C. Experimental arabinose cataracts in young rats. Ophthalmic Res 1977; 9:205-12
31. Patterson JW. Cataractogenic Sugars. Arch Biochem 1955; 58:24-30. [PMID: 13259673.
32. Van Heyningen R. Metabolism of Xylose in the Lens. Biochem J 1959; 73:197-207. [PMID: 13841079.
33. Varma SD, Mikuni I, Kinoshita JH. Flavonoids as inhibitors of lens aldose reductase. Science 1975; 188:1215-6. [PMID: 1145193.
34. Varma SD, Kinoshita JH. Inhibition of aldose reductase by flavonoids. Their possible role in the prevention of diabetic cataracts. Biochem Pharmacol 1976; 25:2505-13. [PMID: 825129.
35. Varma SD. Mizuno, A. and Kinoshita, J.H. Diabetic cataracts and flavonoids. Science 1977; 195:205-6. [PMID: 401544.
36. Kador PF, Akagi Y, Kinoshita JH. The effect of aldose reductase and its inhibition on sugar cataract formation. Metabolism 1986; 35:15-9. [PMID: 3083204.
37. Kador PF, Akagi Y, Takahashi Y, Ikebe H, Wyman M, Kinoshita JH. Prevention of retinal vessel changes associated with diabetic retinopathy in galactose fed dogs by aldose reductase inhibitors. Arch Ophthalmol 1990; 108:1301-9. [PMID: 2119169.
38. Kowluru RA, Tang J, Kern TS. Abnormalities of retinal metabolism in diabetes and experimental Galactosemia, VII. Effect of Long-Term Administration of Antioxidants on the Development of Retinopathy. Diabetes 2001; 50:1938-42. [PMID: 11473058.
39. Varma SD, Kovtun S, Hegde KR, Yin J, Ramnath J. Effect of high sugar on miRNA expression. Studies with galactosemic mice lens. Mol Vis 2012; 18:1609-18. [PMID: 22736950.
40. Varma SD, Morris S. Peroxide damage to the eye lens in vitro prevention by pyruvate. Free Rad Res Common 1988; 4:283-90. [PMID: 3234857.
41. Hegde K, Kovtun S, Varma SD. Prevention of cataract in diabetic mice by topical pyruvate. Clinical Ophthalmology 2011; 5:1141-5. [PMID: 21887096.
42. Varma SD, Devamanoharan PS, Rutzen AR, Ali AH, Henein M. Attenuation of galactose induced cataract by pyruvate. Free Radic Res 1999; 30:253-63. [PMID: 10230804.
43. Hegde KR, Kovtun S, Varma SD. Inhibition of glycolysis in retina by oxidative stress prevention by pyruvate. Mol Cell Biochem 2010; 343:101-5. [PMID: 20559692.
44. Shi X, Dalal NS, Jain AC. Antioxidant behavior of caffeine: efficient scavenging of hydroxyl radicals. Food Chem Toxicol 1991; 29:1-6. [PMID: 1847890.
45. Stadler RH, Fay LB. Antioxidative reactions of caffeine. Formation of 8-oxo-caffeine (1,3,7timethyl uric acid) in coffee subjected to oxidative stress. J Agric. Food em. 1995; 43:13321338
46. Varma SD, Hegde KR, Kovtun S. Effectiveness of topical caffeine in cataract prevention. Studies with galactose cata- ract. Mol Vis 2010; 16:2626-33. [PMID: 21179241.
47. Varma SD, Hegde KR. Kynurenine induced photo oxidative damage in lens in vitro: Protective effect of caffeine. Mol Cell Biochem 2010; 340:49-54. [PMID: 20204679.
48. Resnikoff S, Pascoline D, Etyaale KI, Pokharel GP. Global magnitude of visual impairment caused by uncorrected refractive errors in 2004. Bull World Health Organ 2008; 86:63-70. [PMID: 18235892.
49. Gilbert RM. Caffeine consumption. Prog Clin Biol Res 1984; 158:185-213. [PMID: 6396645.
50. Serafin WE. In: Hardman JG Limbered LE, Molinoff PB, Ruddon RW, In Goodman & Gillman's Pharmacological basis of therapeutics. 9th edition. New York: McGraw Hill; 1996; p. 673-79.
51. Arnaud MJ. The pharmacology of caffeine. Prog Drug Res 1987; •••:273-313. [PMID: 3326033].
52. Wilson DF. Effect of caffeine on neuromuscular transmission in rat. Am J Physiol 1973; 225:862-5. [PMID: 4355178.
53. Dunwiddie TV. Interaction between the effects of adenosine and calcium in synaptic responses in rat hippocampus in vitro. J Physiol 1984; 350:545-59. [PMID: 6086898.
54. Goldstein A, Kaizers S, Warren R. Psychotropic effects of caffeine in man II. Alertness, psychomotor coordination, and mood. J Pharmacol Exp Ther 1965; 150:146-51. [PMID: 5853694.
55. Rousseau E, Ladine J, Liu QY, Meissner G. Activation of the Ca2+ release channel of skeletal muscle sarcoplasmic reticulum by caffeine and related compounds. Arch Biochem Biophys 1988; 267:75-86. [PMID: 2848455.
56. Batting K. The physiological effects of coffee consumption. In: Coffee: Botany, Biochemistry and production of beans and beverage. Ed. MM Clifford and KC Wilson. Publisher: Crown-Helm, London, P 394-439, 1985.
57. Daly JW, Burns RF, Snyder SH. Adenosine receptor in the central nervous system; Relationship to the central actions of methylxanthines. Life Sci 1981; 128:2083-97. [PMID: 6114369.
58. Pedata F, Giovanelli L, De Samo P, Pepeu B. Effect of adenosine derivatives and caffieine on acetylcholine release from the brain synaptomoses: Interaction with muscarinic regulatory mechanisms. J Neurosci 2002; 22:6321-4. [PMID: 12151508.
59. Solinas M, Ferre S, You ZB, Karcz-Kubicha M. Popoli, Goldberg SR. Caffeine induced dopamine and glutamate release in the shell of nucleus accumbens. J Neurosci 2002; 22:6321-4. [PMID: 12151508].
60. Morgan ME, Vestal RE. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry. Life Sci 1989; 45:2025-39. [PMID: 2601563.
61. Degubareff T, Sleator W Jr. Effects of caffeine on the mammalian atrial muscle and interaction with adenosine and calcium. J Pharmacol Exp Ther 1965; 148:202-14. [PMID: 14301011.
62. Blinks JR, Olson CB, Jewell BR, Braverny P. Inf luence of caffeine and other methyl xanthines on the mechanical prop- erties of isolated mammalian heart muscle. Circ Res 1972; 30:367-92. [PMID: 4401230.
63. Dobmeyer DJ, Eeir RA, Greenberg R, Schaal SF. The arrythmogenic effects of caffeine in man. N Engl J Med 1983; 308:814-6. [PMID: 6835272.
64. Beavo JA, Rogers NL, Crawford OB, Hardman JG, Sutherland WW, Newman EV. Effect of xanthine derivatives on lipolysis and on adenosine 3′,5′,-monophosphate phosphodiesterase activity. Mol Pharmacol 1970; 6:597-603. [PMID: 4322367.
65. Ritchie K, Carriere I, De Mendoca A, Portet F, Dartigues JF, Rouaud JF. O BarbergerGateau, Ancelin ML. The neuroprotective effects of caffeine. Neurology 2002; 69:536-45
66. Corley J, Jia X, Kyle Janet AM, Gow AJ, Brett CE, Starr JM, McNeill GM, Deary IJ. Caffeine consumption and cognitive function at age 70: The Lothian birth cohort 1936 study. Psychosom Med 2010; 72:206-14. [PMID: 19995882.
67. Jarvis MJ. Does caffeine intake enhance absolute levels of cognitive performance. Psychopharmacology (Berl) 1993; 110:45-52. [PMID: 7870897.
68. Johnson-Kozlow M, Silversteine DK, Connor EB, Morton D. Coffee and cognitive function in older adults. Am J Epidemiol 2002; 156:842-50. [PMID: 12397002.
69. Lindsay J, Laurin D, Verreault R, Herbert R, Helliwell B, Hill GB, McDowell I. Risk Factors for Alzheimer's disease: A Prospective Analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002; 156:445-53. [PMID: 12196314].
70. Maia L, de Mendoça A. Does caffeine intake protect from Alzheimer's disease? Eur J Neurol 2002; 9:377-82. [PMID: 12099922.
71. Hardy J, Allisop D. Amyloid deposition as the central event in the etiology of Alzheimer's disease. Trends Pharmacol Sci 1991; 12:383-8. [PMID: 1763432.
72. Wenk GL. Neuropathologic changes in Alzheimer's disease. J Clin Psychiatry 2003; 64:7-10. [PMID: 12934968.
73. Turner PR, O'Connor K, Tate WP, Abraham W. C. Role of amyloid precursor protein and its fagments in regulating neural activity, plasticity and memory. Prog Neurobiol 2003; 70:1-32. [PMID: 12927332.
74. Shen ZX. Brain cholinesterase. The molecular and cellular basis of Alzheimer's disease. Med Hypotheses 2004; 63:308-21. [PMID: 15236795.
75. Ross GW, Abbott RD, Petrovitch H, Morens DM, Grandinetti A, Tung KH, Tanner CM, Masaki KH, Blanchette PL, Curb JD, Popper JS, White LR. Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA 2000; 283:2674-9. [PMID: 10819950.
76. Benedetti MD, Bower JH, Maraganore DM, McDonnell SK, Peterson BJ, Ahlskog JE, Schiad DJ, Rocca WA. Smoking, alcohol, and coffee consumption preceding Parkinson's disease. Neurology 2000; 55:1350-8. [PMID: 11087780.
77. Olanow CW, Tatton WG. Etiology and Pathogenesis of Parkinson's disease. Annu Rev Neurosci 1999; 22:123-44. [PMID: 10202534.
78. Dawson TM, Dawson V. Molecular pathways of neurodegeneration in Parkinson's disease. Science 2003; 302:819-22. [PMID: 14593166.
79. Klatsky AL, Morton C, Udaltsova N, Friedman GD. Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166:1190-5. [PMID: 16772246.
80. Corrao G, Zamboni A, Bagnardi V. D'Amico's A, Klatsky A. Coffee, caffeine and the risk of liver cirrhosis. Ann Epide- miol 2001; 11:458-65. [PMID: 11557177.
81. Shiraz T, Tesbin Y, Koriyama S. Coffee consumption and the risk of primary liver cancer. Pooled analysis of two prospec- tive studies in Japan. Int J Cancer 2005; 97:293-300
82. Camden IS, Partovi N, Yoshida EM. Review article: possible beneficial effects of coffee on liver disease and function. Aliment. Pharmacol. 2007; 26:1-819
83. Salazar-Martinez E, Willett WC, Ascherio A, Manson JE, Leitzmann MF, Stampfer MJ, Hu FB. Coffee consumption and risk for type 2diabetes mellitus. Ann Intern Med 2004; 140:1-8. [PMID: 14706966.
84. Huxley R, Lee CM, Barzi F, Timmermeister L, Czernichow S, Perkovic V, Grobbee DE, Batty D, Woodward M. Coffee, decaffeinated coffee, and tea consumption in relation to incident type 2 diabetes mellitus. Arch Intern Med 2009; 169:2053-63. [PMID: 20008687.
85. Hu G, Jousilahti P, Peltonen M, Bidel S, Tuormilehto J. Joint association of coffee consumption and other factors to the risk of type 2 diabetes: a prospective study in Finland. Obesity (London) 2006; 30:1742-9. [PMID: 16652136.
86. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Estimates for the year 2000 and projec- tions for 2030. Diabetes Care 2004; 27:1047-53. [PMID: 15111519.
87. Lopez-Garcia E, van Dam RM, Li TY, Rodriguez-Artalejo F, Hu FB. The relationship of coffee consumption with mortality. Ann Intern Med 2008; 148:904-14. [PMID: 18559841].
88. Neal D. Freedman, Yikyung Park, Christian C. Abnet, Albert R. Hollenbeck, Sinha R. Association of coffee dinking with total and cause specific mortality. N Engl J Med 2010; 366:1891-904
89. Iwai N, Yoshiro H, Kurozawa Y. Relationship between coffee and green tea consumption and all case mortality in a cohort of a rural Japanese population. J Epidemiol 2002; 12:191-8. [PMID: 12164320.
90. Trevithick JR, Chaudun E, Muel AS, Courtois Y, Counis MF. Effect of X-irradiation and vitamin C on DNA degradation and endogenous DNase in embryonic chick lens cells. Curr Eye Res 1987; 6:1275-81. [PMID: 3427977.
91. Zhang DD. Mechanistic studies of the NRF2-KEAP1 signaling pathway. Drug Metab Rev 2006; 38:769-89. [PMID: 17145701].
92. Chan K, Han ZD, Ken YW. An important function of Nrf2 in combating oxidative stress: Detoxification of acetaminophen. Proc Natl Acad Sci USA 2001; 98:4611-6. [PMID: 11287661.
93. Higginbotham EJ, Kilimanjaro HA, Wilensky JT, Batenhorst RL, Hermann D. The effect of c caffeine on intraocular pres- sure in glaucoma patients. Ophthalmology 1989; 96:624-6. [PMID: 2636858.
94. Kang JH, Willet WC, Rosner BA, Hankinson SE, Pasquale LR. Caffeine consumption and the risk of primary open-angle glaucoma: A prospective cohort study. Invest Ophthalmol Vis Sci 2008; 49:1924-31. [PMID: 18263806.
95. Chandrasekaran S, Rochtchina E, Mitchell P. Effect of caffeine on intraocular pressure: The Blue Mountains eye study. J Glaucoma 2005; 14:504-7. [PMID: 16276285.
96. Adams. B and Brubaker R. Caffeine has no clinically significant effect on aqueous humor flow in the normal human eye. Ophthalmology 1990; 97:1030-1. [PMID: 2402413.
97. Chandra P, Gaur A, Varma SD. Effect of caffeine on intraocular pressure of patients with primary open angle glaucoma. Clinical Ophthalmology 2011; 5:1623-9. [PMID: 22140308.
98. Leydhecker W. The water drinking test. Br J Ophthalmol 1950; 34:457-79. [PMID: 15434252.
99. Moura MA, Rodrigues LOC, Weisberg Y, Almeida HG, Carica ES. Effect of submaximal exercise with water ingestion on intraocular pressure in healthy human males. Braz J Med Biol Res 2002; 35:121-5. [PMID: 11743624.
100. Armaly MF, Sayegh RE. Water drinking test. The effect of age on tonometric and tonographic measures. Arch Ophthalmol 1970; 83:176-81. [PMID: 5411529.
101. Agarwal LP, Sharma CK. Two provocative tests for glaucoma. Br J Ophthalmol 1953; 37:330-5. [PMID: 13059267.